The Endomysial Antibody IgA Test at Diagnopein helps in diagnosing celiac disease and related autoimmune intestinal disorders. It offers reliab
The Endomysial Antibody IgA test (commonly called the EMA IgA test) is a specialized blood test that helps detect antibodies directed against endomysium—tissue found in the intestinal lining. This test is mainly used for diagnosing celiac disease, an autoimmune condition where gluten triggers an immune reaction damaging the small intestine.
At Diagnopein, our advanced diagnostic setup ensures high accuracy and reliability in identifying anti-endomysial antibodies (EMA). The EMA IgA test is known for its strong sensitivity and specificity, making it a preferred marker for confirming gluten intolerance or related disorders.
The Endomysial Antibody IgA test plays a crucial role in confirming celiac disease and gluten-sensitive enteropathy. It helps detect immune-mediated intestinal damage before complications arise. Timely testing makes early diagnosis possible, allowing patients to adopt necessary dietary changes and prevent further intestinal injury.
It is particularly important for individuals experiencing symptoms like chronic diarrhea, abdominal bloating, persistent fatigue, nutritional deficiencies, or weight loss. The test is often performed along with Tissue Transglutaminase (tTG) IgA for a more comprehensive assessment.
At Diagnopein, accurate testing methods combined with expert review help your physician confirm diagnosis and design a treatment plan personalized for your health profile.
The Endomysial Antibody IgA test offers several health and diagnostic benefits, including:
Early detection of gluten-induced intestinal disorders
Reliable confirmation of suspected celiac disease
Support in monitoring treatment response after adopting a gluten-free diet
Helpful differentiation between autoimmune digestive disorders
High accuracy through advanced immunofluorescence techniques
Diagnopein ensures stringent quality control for every sample, guaranteeing precision and dependable outcomes. Early and reliable detection not only improves patient comfort but also prevents long-term gastrointestinal complications.
The Endomysial Antibody IgA test procedure is simple and minimally invasive. A certified technician collects a small blood sample from your arm vein. The serum is then analyzed to detect the presence and concentration (titer) of IgA class endomysial antibodies using immunofluorescence microscopy.
Key parameters measured include:
IgA Endomysial Antibody levels
Reference range (Negative: <1:10 titer, Positive: ≥1:10 titer)
Interpretation based on observed fluorescence patterns
Results are generally available within 24–48 hours. If the test result is positive, it usually indicates celiac disease or other autoimmune small intestinal disorders. However, confirmation may require further testing, such as a small intestinal biopsy or tTG antibody test for precise diagnosis.
Diagnopein stands out due to its combination of modern diagnostics and patient-centered care.
High-precision laboratory instruments for accurate antibody detection
Expert pathologists ensuring quality-validated reports
Quick turnaround with easy online report access
Affordable testing packages for better accessibility
Dedicated support and personalized health guidance
Your trust matters to us, and our primary focus is early detection and dependable reporting to support timely medical decisions.
Yes, it is possible to have celiac disease and test negative for EmA IgA, particularly if you have IgA deficiency. In such cases, healthcare providers may use IgG-based tests to aid in diagnosis.
Yes, it is commonly used as part of the diagnostic process for celiac disease, often alongside other antibody tests and clinical evaluations.
Symptoms of celiac disease can include diarrhea, abdominal pain, bloating, weight loss, and fatigue. However, some individuals may be asymptomatic.
The test is generally safe. However, as with any blood draw, there may be minor risks such as bruising, bleeding, or infection at the puncture site.
